Literature DB >> 21208066

Promoting life course vaccination.

Jean-Pierre Michel1, Pierre Olivier Lang.   

Abstract

Infectious diseases remain a significant cause of morbi-mortality in adults aged over 60 years, and many of these diseases are vaccine-preventable (VPDs). There is a pressing need to promote a lifelong vaccine schedule to increase vaccination against VPDs during the different stages of life. We outline the impact of vaccines on the burden of common infectious diseases and consider the negative clinical impact of VPDs in the unvaccinated population. We further illustrate that vaccine uptake is associated with a reduction in the burden of VPDs at any age of life, due to herd immunity. Disability-free and healthy aging is closely linked to childhood health and medical conditions in young adulthood. The midlife vaccine gap drastically impacts health in later life, especially in unvaccinated and older populations. These arguments underline the need for a preventive lifelong health perspective from childhood through old age.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21208066     DOI: 10.1089/rej.2010.1078

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  11 in total

Review 1.  Vaccination in the elderly: what can be recommended?

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

Review 2.  Adult vaccination against tetanus and diphtheria: the European perspective.

Authors:  B Weinberger
Journal:  Clin Exp Immunol       Date:  2016-07-12       Impact factor: 4.330

Review 3.  Vaccination for quality of life: herpes-zoster vaccines.

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Aging Clin Exp Res       Date:  2019-10-23       Impact factor: 3.636

4.  Towards a comprehensive public health response to population ageing.

Authors:  John R Beard; David E Bloom
Journal:  Lancet       Date:  2014-11-06       Impact factor: 79.321

Review 5.  Promoting Healthy Ageing in South Africa Through Vaccination of the Elderly.

Authors:  Mncengeli Sibanda; Johanna C Meyer; Kesentseng J Mahlaba; Rosemary J Burnett
Journal:  Front Public Health       Date:  2021-04-26

6.  Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults.

Authors:  Sara P H van den Berg; Albert Wong; Marion Hendriks; Ronald H J Jacobi; Debbie van Baarle; Josine van Beek
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

7.  Influenza vaccination in the face of immune exhaustion: is herd immunity effective for protecting the elderly?

Authors:  Pierre Olivier Lang; Dimitrios Samaras; Nikolaos Samaras; Sheila Govind; Richard Aspinall
Journal:  Influenza Res Treat       Date:  2012-01-29

8.  Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage.

Authors:  Lauren A Wu; Elisabeth Kanitz; Julie Crumly; Fortunato D'Ancona; Raymond A Strikas
Journal:  Int J Public Health       Date:  2013-01-25       Impact factor: 3.380

9.  Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons.

Authors:  Birgit Weinberger; Michael Schirmer; Raffaella Matteucci Gothe; Uwe Siebert; Dietmar Fuchs; Beatrix Grubeck-Loebenstein
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

10.  Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.

Authors:  Marieke van der Heiden; Annemieke M H Boots; Axel A Bonacic Marinovic; Lia G H de Rond; Marjan van Maurik; Irina Tcherniaeva; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2017-07-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.